Lifestyle Modifications and Nutritional and Therapeutic Interventions in Delaying the Progression of Chronic Kidney Disease: A Review

被引:18
|
作者
Alkhatib, Lean [1 ]
Diaz, Lorena A. Velez [2 ]
Varma, Samyukta [3 ]
Chowdhary, Arsh [4 ]
Bapat, Prachi [5 ]
Pan, Hai [6 ]
Kukreja, Geetika [7 ]
Palabindela, Prasannalaxmi [8 ]
Selvam, Sri Abirami [9 ]
Kalra, Kartik [10 ]
机构
[1] Royal Med Serv, Internal Med, Amman, Jordan
[2] Univ Guayaquil, Med, Guayaquil, Ecuador
[3] Madurai Med Coll, Internal Med, Madurai, India
[4] Smt Kashibai Navale Med Coll & Gen Hosp, Nephrol, Pune, India
[5] Smt Kashibai Navale Med Coll & Gen Hosp, Gen Med, Pune, India
[6] Tianjin Univ Chinese Med, Pathol, Tianjin, Peoples R China
[7] Henry Ford Hlth Syst, Internal Med & Hematol Oncol, Clinton Township, MI USA
[8] Jennie Stuart Hlth, Internal Med, Hopkinsville, KY USA
[9] St Mary Hosp, Internal Med, Langhorne, PA USA
[10] Geisinger Med Ctr, Nephrol, Danville, VA USA
关键词
treatment options for diabetic nephropathy; diabetic kidney disease (dkd); chronic kidney disease (ckd); ckd progression; ckd management; CARDIOVASCULAR RISK; SGLT2; INHIBITORS; HYPERTENSION; ASSOCIATION; FINERENONE; MANAGEMENT; OUTCOMES;
D O I
10.7759/cureus.34572
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) is a debilitating progressive illness that affects more than 10% of the world's population. In this literature review, we discussed the roles of nutritional interventions, lifestyle modifications, hypertension (HTN) and diabetes mellitus (DM) control, and medications in delaying the progression of CKD. Walking, weight loss, low-protein diet (LPD), adherence to the alternate Mediterranean (aMed) diet, and Alternative Healthy Eating Index (AHEI)-2010 slow the progression of CKD. However, smoking and binge alcohol drinking increase the risk of CKD progression. In addition, hyperglycemia, altered lipid metabolism, low-grade inflammation, over-activation of the renin-angiotensin-aldosterone system (RAAS), and overhydration (OH) increase diabetic CKD progression. The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend blood pressure (BP) control of <140/90 mmHg in patients without albuminuria and <130/80 mmHg in patients with albuminuria to prevent CKD progression. Medical therapies aim to target epigenetic alterations, fibrosis, and inflammation. Currently, RAAS blockade, sodium-glucose cotransporter-2 (SGLT2) inhibitors, pentoxifylline, and finerenone are approved for managing CKD. In addition, according to the completed Study of Diabetic Nephropathy with Atrasentan (SONAR), atrasentan, an endothelin receptor antagonist (ERA), decreased the risk of renal events in diabetic CKD patients. However, ongoing trials are studying the role of other agents in slowing the progression of CKD.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] A PREDICTIVE MODEL FOR PROGRESSION OF CHRONIC KIDNEY DISEASE : A SYSTEMATIC REVIEW
    Sabharwal, Alka
    Grover, G.
    Kumar, Shrawan
    INTERNATIONAL JOURNAL OF AGRICULTURAL AND STATISTICAL SCIENCES, 2018, 14 (02): : 637 - 646
  • [42] PREDICTIVE MODELS FOR PROGRESSION OF CHRONIC KIDNEY DISEASE TO KIDNEY FAILURE: A SYSTEMATIC REVIEW
    Ramspek, Chava
    de Jong, Ype
    Dekker, Friedo
    van Diepen, Merel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [43] Chronic kidney disease progression
    Eddy, Allison A.
    Neilson, Eric G.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (11): : 2964 - 2966
  • [44] Progression in chronic kidney disease
    Eddy, AA
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2005, 12 (04) : 353 - 365
  • [45] Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets
    Lim, Yong Jin
    Sidor, Nicole A.
    Tonial, Nicholas C.
    Che, Adrian
    Urquhart, Bradley L.
    TOXINS, 2021, 13 (02)
  • [46] A Review Investigating the Effect of Allopurinol on the Progression of Kidney Disease in Hyperuricemic Patients With Chronic Kidney Disease
    Kabul, Samaneh
    Shepler, Brian
    CLINICAL THERAPEUTICS, 2012, 34 (12) : 2293 - 2296
  • [47] Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions
    Chan, Doris T.
    Watts, Gerald F.
    Irish, Ashley B.
    Dogra, Gursharan K.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (08) : 1274 - 1281
  • [48] Therapeutic interventions for disease progression in Huntington's disease
    Mestre, Tiago
    Ferreira, Joaquim
    Coelho, Miguel M.
    Rosa, Mario
    Sampaio, Cristina
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (03):
  • [49] The Kidney-Gut Axis as a Novel Target for Nutritional Intervention to Counteract Chronic Kidney Disease Progression
    Cabala, Sandra
    Ozgo, Malgorzata
    Herosimczyk, Agnieszka
    METABOLITES, 2024, 14 (01)
  • [50] Connections between vascular calcification and progression of chronic kidney disease: Therapeutic alternatives
    Hruska, KA
    Mathew, S
    Davies, MR
    Lund, RJ
    KIDNEY INTERNATIONAL, 2005, 68 : 142 - 151